AIMS: This study was designed to compare the specific effects of two heart rates (HR), 55 and 75 b.p.m., in patients with heart failure (HF). METHODS AND RESULTS: Patients with chronic HF, left ventricular ejection fraction (LVEF) </= 35%, and a pacemaker with >90% of paced QRS, were included in a randomized cross-over trial of two 3-month periods where pacing rate was set at either 55 or 75 b.p.m. At the end of each period, patients were examined and radionuclide ventriculography, echocardiography, and blood sampling were performed for centralized and blinded analysis. Two patients did not complete the study because of early worsening while paced at 75 b.p.m. Twelve patients completed the study. Compared with 75 b.p.m., pacing at 55 b.p.m. was associated with a higher LVEF [+4.7% (2.6-6.7), P < 0.001], lower B-type natriuretic peptide levels [-91 pg/mL (-148 to -33), P < 0.01], lower systolic pulmonary artery pressure (41 +/- 10 vs. 47 +/- 10 mmHg, P = 0.02) and lower NYHA (New York Heart Association) class (2.2 +/- 0.6 vs. 2.6 +/- 0.5, P = 0.03). The baseline pacing rate prior to inclusion had no effect on results. CONCLUSION: HR per se may impact cardiac function and low HR might be beneficial in patients with systolic HF compared with intermediate HR.
RCT Entities:
AIMS: This study was designed to compare the specific effects of two heart rates (HR), 55 and 75 b.p.m., in patients with heart failure (HF). METHODS AND RESULTS:Patients with chronic HF, left ventricular ejection fraction (LVEF) </= 35%, and a pacemaker with >90% of paced QRS, were included in a randomized cross-over trial of two 3-month periods where pacing rate was set at either 55 or 75 b.p.m. At the end of each period, patients were examined and radionuclide ventriculography, echocardiography, and blood sampling were performed for centralized and blinded analysis. Two patients did not complete the study because of early worsening while paced at 75 b.p.m. Twelve patients completed the study. Compared with 75 b.p.m., pacing at 55 b.p.m. was associated with a higher LVEF [+4.7% (2.6-6.7), P < 0.001], lower B-type natriuretic peptide levels [-91 pg/mL (-148 to -33), P < 0.01], lower systolic pulmonary artery pressure (41 +/- 10 vs. 47 +/- 10 mmHg, P = 0.02) and lower NYHA (New York Heart Association) class (2.2 +/- 0.6 vs. 2.6 +/- 0.5, P = 0.03). The baseline pacing rate prior to inclusion had no effect on results. CONCLUSION: HR per se may impact cardiac function and low HR might be beneficial in patients with systolic HF compared with intermediate HR.
Authors: Nidas A Undrovinas; Victor A Maltsev; Luiz Belardinelli; Hani N Sabbah; Albertas Undrovinas Journal: J Physiol Sci Date: 2010-05-19 Impact factor: 2.781
Authors: Sudhish Mishra; Vitaliy Reznikov; Victor A Maltsev; Nidas A Undrovinas; Hani N Sabbah; Albertas Undrovinas Journal: J Physiol Date: 2014-11-17 Impact factor: 5.182
Authors: Ermenegildo de Ruvo; Francesco Sebastiani; Luigi Sciarra; Alessandro Fagagnini; Leonardo Calo Journal: Indian Pacing Electrophysiol J Date: 2011-10-02
Authors: Michael Böhm; Michele Robertson; Jeffrey Borer; Ian Ford; Michel Komajda; Felix Mahfoud; Sebastian Ewen; Karl Swedberg; Luigi Tavazzi Journal: J Am Heart Assoc Date: 2016-02-12 Impact factor: 5.501